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Abstract A His-tagged derivative of the multidrug e¥ux pump
AcrB could be crystallized in three di¡erent space groups (R3,
R32 and P321). Experimental MAD-phasing maps from R32
AcrBHis crystals were obtained to a resolution of 3.5 A+ . Data-
sets of native and substrate soaked AcrBHis crystals were col-
lected at the Swiss Light Source X06SA beamline up to a res-
olution of 2.7 A+ and re¢nement of these data provided good
quality electron density maps, which allowed us to complement
the published AcrB structure (PDB code 1iwg). Introduction of
amino acids 860^865 and 868 lacking in the 1iwg structure and
deletion of a highly disordered region (amino acids 669^678)
improved Rfree and average B factors in the 2.7 A+ model. We
could not identify signi¢cant densities indicating speci¢c anti-
biotic binding sites in the AcrB R32 space group datasets under
the soaking conditions tested.
: 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Bacteria have evolved three general mechanisms of resis-
tance towards antibiotics: (i) resistance by target modi¢ca-
tion; (ii) resistance by antibiotic modi¢cation; and (iii) resis-
tance through the action of antibiotic e¥ux pumps.
Membrane protein pumps responsible for the latter type of
resistance can be classi¢ed as (i) ABC-type antibiotic resis-
tance pumps, which utilize the free energy of adenosine tri-
phosphate (ATP) hydrolysis to energize the e¥ux of toxic
compounds over the membrane or (ii) secondary antibiotic
e¥ux pumps which use the electrochemical gradient of ions
across the membrane in an antiport modus to energize e¥ux
processes.
Secondary antibiotic/multiple drug resistance transporters
can be divided into four families [1,2] : (i) major facilitator
superfamily (MFS); (ii) small multidrug resistance family
(SMR); (iii) multidrug and toxic compound extrusion family
(MATE); and (iv) resistance nodulation cell division super-
family (RND, TC# 2.A.6). Members of the RND superfamily
involved in the transport of antibiotics belong to the family of
the (largely Gram-negative bacterial) hydrophobe/amphiphile
e¥ux-1 (HAE1) family (TC# 2.A.6.2). The proton motive
force-driven RND/HAE1 drug/Hþ antiporters usually func-
tion within a tripartite system including an outer membrane
channel (outer membrane factor family (OMF, TC# 1.B.17))
and a member of the membrane fusion protein family (MFP,
TC# 8.A.1) (Fig. 1). The drug e¥ux is believed to occur via
the initial binding of the drug to the RND component and
subsequent transport through the OMF. The role of the MFP
is still puzzling, although it has been shown that it is abso-
lutely essential for the function of the whole pump [3^5]. Be-
sides the well-studied RND^MFP^OMF systems in Pseudo-
monas aeruginosa (e.g. MexAB-OprM and MexCD-OprJ) [6],
the AcrAB^TolC tripartite system is currently the most
studied due to the structural information on the AcrB and
TolC components [7^9]. The substrate speci¢city of the
AcrAB^TolC system is rather broad: anionic, cationic and
zwitterionic as well as neutral compounds are transported,
including £uoroquinolones, macrolides and phenylpropa-
noids. Most of the substrates are hydrophobic and can
traverse the inner membrane. A notable exception are the
L-lactams transported by the system [10]. TolC has been struc-
turally characterized to a resolution of 2.1 AH by crystallo-
graphic means [9]. Apart from the membrane-embedded re-
gions (about 4 nm thickness), a TolC trimer has a 10 nm
periplasmic barrel domain composed of 12 K-helices, which
form a long conduit through which the drugs might be trans-
ported. The crystallization and structural analysis of AcrB
have been described recently [8,11]. Like TolC, AcrB forms
a homotrimer, which is believed to be its functional unit. Each
AcrB monomer contains 12 membrane spanning K-helices and
a large periplasmic domain (Fig. 2A). The transmembrane K-
helices in the AcrB trimer are organized in a way that these
encircle a 35 AH wide cavity, which is believed to be ¢lled with
phospholipids in vivo (Fig. 2B). Within each monomer, trans-
membrane helices 4 and 10, encircled by the other transmem-
brane helices of the monomer, harbor the residues Lys940
(helix 10) and Asp407 and 408 (helix 4), which are postulated
to be important for the Hþ translocation (Fig. 2B and [8]).
The periplasmic domain can be divided into two major parts:
the TolC docking domain and the pore domain. The TolC
docking domain exhibits a funnel-like structure narrowing
to the central pore located in the pore domain. The internal
diameter on the top of the funnel is about the same as the
diameter of the TolC periplasmic conduit. The central pore
structure consists of three K-helices, one donated by each
AcrB monomer (Fig. 2C). Another remarkable feature is a
long loop protruding from one monomer through the neigh-
boring monomer. These loops appear to make the main and
almost only interaction between the monomers. At the prox-
0014-5793 / 03 / $30.00 K 2003 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(04)00272-8
*Corresponding author. Fax: (41)-1-632 5523.
E-mail address: pos@micro.biol.ethz.ch (K.M. Pos).
Abbreviations: CHM, cyclohexyl-n-hexyl-L-D-maltoside; SeMet,
selenomethionine
FEBS 28227 15-4-04 Cyaan Magenta Geel Zwart
FEBS 28227 FEBS Letters 564 (2004) 333^339
imal end of the central pore, the structure opens up to a
central cavity, leading to the cavity in the transmembrane
part. Moreover, three entrances or vestibules reaching to-
wards the central cavity are located just above the membrane
plane. From the AcrB native structure a drug transport model
has been postulated [8,12] which involves the transport of
membrane permeable drugs from the inner lea£et of the cy-
toplasmic membrane through a groove formed by transmem-
brane helices 8 and 9 towards the central cavity. L-Lactam
antibiotics are believed to enter the central cavity via the
vestibules. Once in the central cavity, the substrates are be-
lieved to be transported into the external medium through the
central pore (which has to open ¢rst), through the funnel part
of the AcrB periplasmic domain and ¢nally through TolC.
Currently, the elucidation of the molecular mechanism(s) of
transport of the wide variety of substrates is a major chal-
lenge. The substrate binding and speci¢city has already been
addressed by structural and functional studies. It has been
shown that the periplasmic part of the RND component is
responsible for the substrate speci¢city of the whole tripartite
system. This has been demonstrated for AcrB, MexB, MexD,
and MexY [13^15]. Additionally, structural analysis of bind-
ing of antibiotics to AcrB (based on 3.5^3.8 AH data) has been
reported recently [7]. Binding of four AcrB substrates, rhoda-
mine G6, ethidium, dequalinium and cipro£oxacin is observed
in the central cavity. For all substrates except cipro£oxacin,
Phe386 (helix 3) was one of the main hydrophobic contacts, in
fact in the case of ethidium it seemed to be the only one. For
dequalinium, only the top quinolinium moiety was close to
the charged residues Asp99 and 101 but the bottom quinoli-
nium moiety was close to only Phe386. For cipro£oxacin,
Phe458 and 459 (helix 5) were the main ligands. Binding of
three substrate molecules per trimer was observed as enforced
by the three-fold symmetry of the R32 space group. Another
observation was an 1‡ outward tilting of the periplasmic do-
main, postulated to be induced by the substrate binding [7].
We report here on the crystallographic analysis of di¡rac-
tion data obtained (up to 2.7 AH ) with crystals from native
AcrBHis, a selenomethionine (SeMet) substituted derivative
and substrate soaked derivatives of AcrBHis.
2. Materials and methods
2.1. Crystal optimization and SeMet substitution
Expression of acrBHis, preparation of membranes, puri¢cation and
initial crystallization of AcrBHis are described in Pos and Diederichs
[11]. To obtain SeMet substituted AcrB, Escherichia coli C43(DE3)/
Fig. 1. Hypothetical structure of tripartite e¥ux pumps in Gram-negative bacteria, e.g. the AcrAB^TolC e¥ux pump from E. coli (adapted
from Nikaido and Zgurskaya [10]).
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pET24acrBHis was grown in methionine deprived minimal media in-
cluding SeMet. Yields were 6 mg of SeMet substituted AcrBHis from
1 l of minimal media culture. SeMet crystals (200U200U100 Wm3)
were grown using 0.1 M Na-HEPES, pH 7.5, 10^60 mM NaCl and
8% (w/v) PEG 4000 as precipitant and protein at 39 mg/ml in a
hanging drop (1:1 dilution) experimental setup over a 0.5 ml precip-
itant solution in the reservoir. Crystals which belong to the space
group R32 were frozen in liquid ethane using glycerol as cryoprotec-
tant. AcrBHis R3 crystals were obtained using 17 mg/ml protein di-
luted 1:1 in 0.1 M Na-HEPES, pH 7.5, 50 mM NaCl, 5% (v/v)
glycerol and 5% (w/v) PEG 4000 as precipitant in a hanging drop
experimental setup over a 0.5 ml precipitant solution in the reservoir.
P321 crystals (about 100U100U10 Wm3) were obtained using 70 mM
Na-citrate, pH 4.6, 8% (v/v) glycerol and 16% (v/v) PEG 400 as
precipitant (1:1 dilution, hanging drop). For freezing these crystals,
solid glucose was added to the droplet containing the crystal and
allowed to saturate the drop in a stepwise manner. Large single native
AcrBHis (R32) crystals with dimensions up to 1000U800U400 Wm3
were obtained by adding isopropyl-L-D-thiogalactopyranoside, n-dec-
anoylsucrose, n-nonyl-L-D-thiomaltoside or n-octyl-L-D-thiomaltoside
(at 1% (w/v), 2.5, 3.2 and 9 mM ¢nal concentration, respectively).
AcrBHis was used at 16.8 mg/ml. Crystals were transferred in 11 steps
to 0.1 M Na-HEPES, pH 7.5, 5% (w/v) PEG 4000, 0.1 M NaCl and
0.05% (w/v) cyclohexyl-n-hexyl-L-D-maltoside (CHM) solutions con-
taining 2^30% (v/v) glycerol in 5^10 min intervals. After the ¢nal
soaking step at 30% (v/v) glycerol, the crystals were directly frozen
Fig. 2. A: Backbone ribbon diagram side view of AcrB trimer. B: Topology of the transmembrane helices top view along the crystallographic
three-fold axis. The three monomers enclose a 30^35 AH wide cavity. C: Backbone periplasmic top view along the crystallographic three-fold
axis. The long loops protruding from one monomer into the next provide the main interaction within the AcrB trimer. The protomers are indi-
vidually colored. Figures are Pymol (www.pymol.org) drawings based on the coordinates deposited in the PDB databank entry 1iwg [8].
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into liquid propane or ethane and stored in liquid nitrogen. In soaking
experiments, crystals were treated using the same procedure in the
presence of 0.5^5 mM bile salt or antibiotic.
2.2. X-ray di¡raction dataset analysis and re¢nement procedure
Datasets from native crystals and heavy atom derivatives were col-
lected at the DESY, Hamburg, Germany, EMBL beamlines BW7A,
BW7B and X11. Native and substrate co-crystals as well as the MAD
data were measured either at beamline X06SA of the Swiss Light
Source (Paul Scherrer Institut, Villigen, Switzerland) or at beamline
ID29 of the ESRF (Grenoble, France). Data reduction was done with
the XDS Software package [16]. The SeMet substructure of the SeMet
derivative crystals was solved with SHELXD [17]. A total of 35 sele-
nium sites out of 42 theoretically possible sites could be detected.
Further re¢nement of the heavy atom positions was carried out
with the program SHARP [18]. Solvent £attening with RESOLVE
[19,20] resulted in interpretable maps at a resolution of 3.5 AH . The
structures in the other space groups were solved by molecular replace-
ment using MOLREP [21]. As search models 1iwg and a modi¢ed
version of 1iwg (model2, see Section 3) were used. All structures were
re¢ned with the program REFMAC5 [22] starting with 20 cycles of
rigid body re¢nement with four rigid domains consisting of residues
(i) 1^30 and 334^530, (ii) 31^333, (iii) 561^859 and (iv) 531^560 and
860^1031, followed by 20 cycles of restrained re¢nement. Model
building was done using the program ‘O’ [23]. Fig. 2 was created using
Pymol (www.pymol.org) and Figs. 3 and 4 were created using DINO
(www.dino3d.org).
3. Results and discussion
3.1. Di¡raction quality of AcrBHis crystals
The ¢rst crystals of AcrBHis in space group R32 were ob-
tained in a screening procedure using the MembFac screen of
Hampton (solution 30) and were rather sensitive to radiation
damage [11]. The initial cryoprotection procedures led to
cracking of larger crystals while freezing them in liquid nitro-
gen. These problems could be overcome by the optimization
of the crystallization conditions and freezing protocol. Crys-
tals grown in the presence of n-nonyl-L-D-thiomaltoside and n-
octyl-L-D-thiomaltoside were transferred into cryoprotection
solutions containing 1 mM erythromycin or novobiocin, re-
spectively, in the case of substrate binding studies. After the
¢nal soaking step, the crystals were directly frozen in liquid
propane or ethane and stored in liquid nitrogen. This proce-
Fig. 3. Stereo view displaying the region 860^868 with (A) the Fo3Fc map at 2.7 AH contoured at 3c in red and (B) 2Fo3Fc electron density
map at 2.7 AH contoured at 1c in blue. Shown in bold sticks from top to bottom are the residues Trp859 and the amended residues Thr860,
Gly861, Met862, Ser863, Tyr864, Gln865, Leu868 and Ser869.
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dure improved the di¡raction of the crystals to a resolution of
2.7 and 2.8 AH , for the native and substrate soaked crystals,
respectively.
AcrB could be crystallized in two other space groups, R3
and P321. R3 crystals were obtained using the same crystal-
lization conditions as described for R32 crystals, but with
addition of 5% (v/v) glycerol in the mother liquor and 2.5%
(v/v) glycerol in the initial protein droplet condition. These
crystals (350U350U300 Wm3) di¡racted to 3.0 AH resolution.
P321 crystals (about 100U100U10 Wm3) were obtained using
70 mM Na-citrate, pH 4.6, 8% glycerol and 16% (v/v) PEG
400 as precipitant. These crystals were frozen using glucose as
cryoprotectant. One dataset has been collected to a resolution
of 3.5 AH .
3.2. Structure solution and re¢nement
In order to obtain phase information, R32 crystals were
soaked with various heavy atom compounds. Despite good
datasets (to 3.0 AH resolution), phases could not be determined
due to severe non-isomorphism. Especially the c-axis of the
crystal unit cell varied drastically (between 490 and 520 AH ),
which made direct comparison of the datasets impossible. We
therefore produced crystals of SeMet substituted AcrBHis and
collected MAD data (Table 1). After determining phases using
the programs SHELXD, SHARP and RESOLVE, interpret-
able electron density maps were obtained at 3.5 AH resolution.
During the process of model building, Murakami et al. [8]
published a structure of AcrB based on 3.5 AH di¡raction
data. Their model (PDB database entry 1iwg) was used in
the initial re¢nement procedures with our di¡raction data.
The re¢nement statistics listed in Table 2 clearly demon-
strate that our experimental data from native and substrate
soaked crystals produced models of AcrB with high Rfree val-
ues after rigid body and restrained re¢nement. The highest
Rfree values were observed with data from a R32 crystal
soaked with taurocholate (m215, 3.1 AH , Rfree = 42.6%) and
with the native R3 crystal dataset (m1, 3.0 AH , Rfree = 41.8%).
The best Rfree values were obtained with the native crystal
dataset m237 (3.0 AH , Rfree = 36.2%) and the data from the
novobiocin soaked crystal m228 (2.8 AH , Rfree = 35.8%). In
comparison, the 1iwg structure published by Murakami et
al. [8] yielded an Rfree value of 35.5% (at 3.5 AH ) and the
unliganded structure 1oy6 published by Yu et al. [7] showed
an Rfree of 33.0% at 3.7 AH . The average B factors from the
re¢ned structures based on 1iwg are in almost all cases above
100 AH 2, with the notable exception of the m1 3.0 AH dataset in
Fig. 4. Trimer central cavity region near Phe386 (bold stick): Stereo view of Fo3Fc electron density maps at 2.9 AH contoured at 3c : blue:
m209 (native), green: m227 (erythromycin soaked), red: m228 (novobiocin soaked).
Table 1
Data collection and crystallographic analysis
Peak SeMet in£ection Remote Native Native Native
Space group R32 R32 R3 P321






Wavelength (AH ) 0.9792 0.9791 0.9756 0.9774 0.9796 0.9790
Resolution (AH ) 3.5 3.5 3.5 2.65 3.2 3.5
Observations 323 212 438 015 289 466 539 666 127 510 313 867
Unique re£ections 52 275 52 273 50 259 59 390 66 801 25 414
Completeness (%) 99.9 99.9 96.1 99.2 99.0 99.9
I/c(I) 7.0 7.4 9.4 15.5 5.4 10.3
Rmerge (%) 30.1 32.4 23.3 8.2 9.9 19.8
RmrgdFa (%) 24.1 23 19.8 7.3 21.5 16.8
Anomalous phasing power (acentric) 1.6 0.9 1.5
Overall ¢gure of merit : 0.47
aRmrgdF is a measure for the quality of the reduced amplitudes [24].
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R3 (61.6 AH 2). High average B factors were also found for the
structures 1iwg [8] and 1oye [7].
Due to disorder, the 1iwg AcrB model lacks regions 1^6,
499^512, 860^868 and 1037^1049 [8]. Inspection of our Fo3Fc
and 2Fo3Fc maps obtained with datasets m1, m209, m227
and m228 (Table 2) revealed the presence of interpretable
density in the region of residues 860^868 (Fig. 3a and b).
We amended the model in this region by implementing amino
acid residues 860^865 and 868. Furthermore, we corrected the
side chain location of Glu112 (pore region) and His596 and
deleted amino acids 669^678 due to poor electron density. The
modi¢ed model (designated model2) resulted in slightly better
Rfree factors in the re¢nement cycle compared to the same
re¢nement done with 1iwg (Table 2). The best Rfree factor
was obtained with the datasets from native R32 crystals using
this modi¢ed model. Re¢nement against data from crystal
m237 yielded an R factor of 32.9% and Rfree of 35.0%. The
electron density in the omitted region 669^678 after re¢ne-
ment with model2 is di⁄cult to interpret and requires further
analysis before an alternate chain progression can be deter-
mined. Remarkably, the B factors dropped approximately
10^30% compared to the re¢ned 1iwg structure (Table 2).
3.3. Substrate binding studies
We have tested several compounds (erythromycin, novobio-
cin, taurocholate, taurodeoxycholate, lome£oxacin, cipro£ox-
acin, deoxycholate, chloramphenicol and Hoechst 33342) for
binding to AcrBHis by crystal soaking experiments and occa-
sionally by co-crystallization. All data obtained from com-
pound soaked crystals resulted in higher R factors, with the
exception of m228 (novobiocin soak, Rfree = 35.8% with 1iwg
and 36.8% with model2). Very high R factors were obtained
with the lome£oxacin and erythromycin soaked crystal data-
sets m222 and m227 ( = 40%). In comparison, Yu et al. [7]
reported almost equal Rfree factors for the unliganded and
liganded structures (32^34%) at 3.5^3.8 AH . Our experimental
setup di¡ers from that described in Yu et al. [7] by (i) the
presence of a His-tag at the C-terminus of the protein, (ii) a
higher pH of the soaking bu¡er (7.5 versus 5.6 and 6.6) and
(iii) the use of CHM (0.05%) rather than dodecyl-L-D-malto-
side (DDM) (0.1%) as detergent. Furthermore, in the deter-
mination of drug binding sites, Yu et al. [7] used electron
density omit maps directly after data scaling and molecular
replacement, before doing any re¢nement. We calculated the
Fo3Fc and 2Fo3Fc maps (Fig. 4) after molecular replacement
Table 2
Re¢nement statistics after rigid body and restrained re¢nement
Crystal name Resolution range
(AH )




Average B factor (AH 2)
M1 (R3 native)
1iwg 19.7^3.0 36.2 41.8 0.013 1.48 61.6
model2 19.7^3.0 36.0 41.1 0.013 1.42 61.6
M209 (native)
1iwg 19.5^2.65 34.1 37.2 0.009 1.19 100.7
model2 182.5^2.65 34.5 36.4 0.010 1.27 67.5
M210 (native)
1iwg 19.8^3.0 37.0 39.0 0.011 1.32 110.0
model2 19.8^3.0 35.6 37.0 0.013 1.40 74.7
M237 (native)
1iwg 46.6^3.0 33.5 36.2 0.011 1.32 102.8
model2 46.6^3.0 32.9 35.0 0.011 1.32 76.3
M238 (native+IPTG)
1iwg 46.6^2.9 37.3 39.8 0.011 1.32 118.7
model2 46.6^2.9 35.6 38.7 0.012 1.37 91.5
M198 (Hoechst 33342)
1iwg 47.7^2.9 37.6 39.7 0.010 1.28 109.0
model2 47.7^2.9 34.7 38.4 0.011 1.29 85.4
M215 (taurocholate)
1iwg 47.1^3.1 40.1 42.6 0.011 1.32 112.2
model2 47.1^3.1 37.6 39.4 0.013 1.41 90.9
M216 (taurocholate)
1iwg 46.6^3.0 35.5 39.3 0.011 1.32 114.7
model2 46.6^3.0 33.5 37.7 0.011 1.34 88.4
M222 (lome£oxacin)
1iwg 47.7^3.1 40.0 41.4 0.013 1.41 112.6
model2 47.7^3.1 38.8 40.3 0.015 1.50 95.1
M227 (erythromycin)
1iwg 46.6^2.9 34.0 39.9 0.011 1.28 98.1
model2 46.6^2.9 34.3 40.1 0.011 1.26 73.4
M228 (novobiocin)
1iwg 47.7^2.8 33.1 35.8 0.010 1.27 105.6
model2 47.7^2.8 33.9 36.8 0.010 1.26 81.6
M240 (erythromycin)
1iwg 46.1^3.1 36.1 40.2 0.011 1.36 124.7
model2 46.1^3.1 33.4 37.8 0.013 1.42 104.1
M241 (erythromycin)
1iwg 47.0^3.0 33.8 37.7 0.012 1.42 109.3
model2 47.1^3.0 34.8 37.1 0.013 1.43 92.9
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and re¢nement (rigid body and restrained re¢nement with
REFMAC5). Inspection of Fo3Fc di¡erence maps using our
substrate soaked crystal datasets did not reveal any signi¢cant
positive density features di¡erent from the ones observed with
the native datasets (Fig. 4). The 2Fo3Fc maps of m209 (na-
tive), m227 (erythromycin soaked crystal) and m228 (novobio-
cin soaked crystal) at 2.7^2.8 AH all showed similar density
features (not shown). Despite the good resolution of the den-
sity maps (2.8 AH ), we were not able to identify di¡erence
density features that could be attributed to bound ligands.
A possible reason for this is the low quality of the phases
derived from a high R factor model. We expect that a future
improvement of the AcrB model (with lower Rfree) might lead
to the unambiguous identi¢cation of substrate binding sites,
allowing a deeper understanding of the functional aspects of
AcrB.
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